drugset / Trial / NCT01748864

Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers

NCT01748864

Phase 1 Completed 23 enrolled Endocyte
NaSingle-groupOpen-labelDiagnostic

Summary

A Phase 1, single-center, open-label, single arm, baseline-controlled (for safety) study in normal volunteers. Study will determine biodistribution and excretion of the radioactive drug substance and evaluate the safety and tolerability of 99mTC-Etarfolatide in normal volunteers.

Timeline

Start
2013-04
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject EC20 Diagnostic / imaging agent

Indications

No indication recorded.